Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Dragonfly Therapeutics
Stanford University
AstraZeneca
Genmab
Seagen Inc.
Seagen Inc.
Fondazione del Piemonte per l'Oncologia
Fred Hutchinson Cancer Center
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, Davis
Emory University
Ohio State University
Hoffmann-La Roche
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
Deciphera Pharmaceuticals, LLC
STORM Therapeutics LTD
Peking University Cancer Hospital & Institute
Pfizer
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
ViroMissile, Inc.
Hummingbird Bioscience
Erasca, Inc.
University of Cincinnati
Bristol-Myers Squibb
AstraZeneca
Bayer
Pfizer
Washington University School of Medicine
University of Florida
Radiopharm Theranostics, Ltd
Pfizer
Arvinas Inc.
Tizona Therapeutics, Inc
Boehringer Ingelheim
Aulos Bioscience, Inc.
M.D. Anderson Cancer Center